Trial intelligence / Profile preview

Human erythropoietin for acute traumatic cervical spinal cord injury

IRCT2014122920471N1Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jan 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of erythropoietin in acute cervical spinal cord injury (ACSCI), sponsored by Shiraz University of Medical Sciences. Started Jan 2012; status: completed.

02

Drugs

erythropoietin
03

Conditions

acute cervical spinal cord injury (ACSCI)

Beyond the preview

Go deeper on IRCT2014122920471N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014122920471N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call